• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含5,6-二氢吡啶-2-酮支架的非肽α(v)β(3)/α(5)β(1)整合素双重拮抗剂的合成与生物学评价

Synthesis and biological evaluation of non-peptide alpha(v)beta(3)/alpha(5)beta(1) integrin dual antagonists containing 5,6-dihydropyridin-2-one scaffolds.

作者信息

Benfatti Fides, Cardillo Giuliana, Fabbroni Serena, Galzerano Patrizia, Gentilucci Luca, Juris Riccardo, Tolomelli Alessandra, Baiula Monica, Spartà Antonino, Spampinato Santi

机构信息

Dipartimento di Chimica "G. Ciamician", Università di Bologna, Via Selmi 2, 40126 Bologna, Italy.

出版信息

Bioorg Med Chem. 2007 Dec 1;15(23):7380-90. doi: 10.1016/j.bmc.2007.07.049. Epub 2007 Aug 22.

DOI:10.1016/j.bmc.2007.07.049
PMID:17869121
Abstract

Small constrained non-peptidic molecules consisting of a polyfunctionalized rigid core, carrying appendages corresponding to arginine and aspartic acid side chains, have been recently reported to be promising for drug development. In this work, the 5,6-dihydropyridin-2-one was envisaged as a scaffold to turn into potential integrin ligands, introducing a carboxylic acid and a basic appendage. The synthesis and the antiadhesion activity of a small library of peptidomimetics capable to recognize alpha(v)beta(3) and alpha(5)beta(1) integrins has been herein reported.

摘要

最近有报道称,由多官能化刚性核心组成、带有对应于精氨酸和天冬氨酸侧链的附属基团的小分子受限非肽类分子在药物开发方面很有前景。在这项工作中,5,6 - 二氢吡啶 - 2 - 酮被设想为一种骨架,通过引入羧酸和碱性附属基团转化为潜在的整合素配体。本文报道了一个能够识别α(v)β(3)和α(5)β(1)整合素的拟肽小分子文库的合成及其抗黏附活性。

相似文献

1
Synthesis and biological evaluation of non-peptide alpha(v)beta(3)/alpha(5)beta(1) integrin dual antagonists containing 5,6-dihydropyridin-2-one scaffolds.含5,6-二氢吡啶-2-酮支架的非肽α(v)β(3)/α(5)β(1)整合素双重拮抗剂的合成与生物学评价
Bioorg Med Chem. 2007 Dec 1;15(23):7380-90. doi: 10.1016/j.bmc.2007.07.049. Epub 2007 Aug 22.
2
Antiangiogenic effect of dual/selective alpha(5)beta(1)/alpha(v)beta(3) integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics.双重/选择性α(5)β(1)/α(v)β(3)整合素拮抗剂的抗血管生成作用,该拮抗剂基于部分修饰的反式-内消旋环四肽模拟物设计。
J Med Chem. 2010 Jan 14;53(1):106-18. doi: 10.1021/jm9013532.
3
Design and synthesis of a new class of selective integrin alpha5beta1 antagonists.新型选择性整合素α5β1拮抗剂的设计与合成
J Med Chem. 2007 Aug 9;50(16):3786-94. doi: 10.1021/jm070002v. Epub 2007 Jul 6.
4
Synthesis and initial evaluation of novel, non-peptidic antagonists of the alpha(v)-integrins alpha(v)beta(3) and alpha(v)beta(5).新型α(v)整合素α(v)β(3)和α(v)β(5)非肽类拮抗剂的合成与初步评价
Bioorg Med Chem Lett. 2009 Jan 15;19(2):352-5. doi: 10.1016/j.bmcl.2008.11.074. Epub 2008 Nov 24.
5
Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.利用基于结构的药物设计鉴定新型短链4-取代吲哚作为有效的αvβ3拮抗剂
Eur J Med Chem. 2007 Mar;42(3):334-43. doi: 10.1016/j.ejmech.2006.10.015. Epub 2006 Dec 20.
6
Novel potent and selective alphavbeta3/alphavbeta5 integrin dual antagonists with reduced binding affinity for human serum albumin.对人血清白蛋白结合亲和力降低的新型强效选择性αvβ3/αvβ5整合素双重拮抗剂。
Eur J Med Chem. 2006 Jul;41(7):847-61. doi: 10.1016/j.ejmech.2006.03.008. Epub 2006 May 11.
7
Development of isoxazoline-containing peptidomimetics as dual αvβ3 and α5β1 integrin ligands.合成含异噁唑啉的肽模拟物作为双重 αvβ3 和 α5β1 整合素配体。
ChemMedChem. 2011 Dec 9;6(12):2264-72. doi: 10.1002/cmdc.201100372. Epub 2011 Sep 26.
8
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity.基于三环药效团的分子作为新型整合素α(v)β3拮抗剂。第1部分:具有α(v)β3/α(IIb)β3双重拮抗活性的先导化合物的设计与合成。
Bioorg Med Chem. 2006 Apr 1;14(7):2089-108. doi: 10.1016/j.bmc.2005.10.060. Epub 2005 Nov 23.
9
Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity.发现一种具有体内抗肿瘤活性的(1H-苯并咪唑-2-基)-1H-吡啶-2-酮(BMS-536924)胰岛素样生长因子I受体激酶抑制剂。
J Med Chem. 2005 Sep 8;48(18):5639-43. doi: 10.1021/jm050392q.
10
Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells.单细胞追踪分析揭示了选择性小分子非肽类α5β1或αvβ3/β5整合素拮抗剂对U87MG胶质瘤细胞的相反作用。
Biochim Biophys Acta. 2014 Sep;1840(9):2978-87. doi: 10.1016/j.bbagen.2014.04.024. Epub 2014 May 5.

引用本文的文献

1
Side chain effect in the modulation of αβ/αβ integrin activity via clickable isoxazoline-RGD-mimetics: development of molecular delivery systems.通过可点击异恶唑啉-RGD模拟物调节αβ/αβ整合素活性中的侧链效应:分子递送系统的开发
Sci Rep. 2020 May 4;10(1):7410. doi: 10.1038/s41598-020-64396-4.